Bulletin Contents
Search
Home Page
 
*Cotinga Pharmaceuticals Inc 
Listed Company 

CRITICAL OUTCOME TECHNOLOGIES INC. ("COT")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: January 22, 2015
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced December 19, 2014:

Number of Shares: 970,000 common shares

Purchase Price: $0.255 per share

Warrants: 970,000 share purchase warrants attached to purchase 970,000 shares

Warrant Exercise Price: $0.38 for a five year period

Number of Placees: 5 Placees

Finder's Fees: An aggregate of $5,100 plus 20,000 finder's warrants (each exercisable into one common share at a price of $0.29 for a five year period) is payable to BMO Nesbitt Burns and Dundee Securities Ltd.

Pursuant to Corporate Finance Policy 4.1, Section 1.11(d), the Company has issued a news release announcing the closing of the private placement and setting out the expiry dates of the hold period(s). Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.
________________________________________